Exposure of human multiple myeloma cells to Tetrac typically results in caspase-9 and caspase-3 activation but not activation of the DNA-cleaving apoptosis inducing factor (AIF) (Cohen et al., 2018). Here, AIFM1 is linked to plasma cell myeloma.